Clinical trial
Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower…
NCT00493051 · Tissue Repair Company, Industry · Completed
Key facts
| NCT number | NCT00493051 |
|---|---|
| Title | Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Single- and Double-Dose, Comparator Arm (Standard of Care), Multicenter Phase 2b Study of Topical GAM501 (Ad5PDGF-B/Bovine Type I Collagen Gel) in the Treatment of Non-Healing Diabetic Ulcers of the Lower Extremities |
| Acronym | MATRIX |
| Lead sponsor | Tissue Repair Company, Industry |
| Collaborators | Cardium Therapeutics Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Foot |
| Intervention type | Biological, Other |
| Interventions | GAM501, Placebo, Standard of care |
| Enrollment | 124 |
| Start date | Nov 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 27, 2007 |
| Last update posted | Feb 10, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: